Last week, CluePoints joined us in Las Vegas at Partnerships in Clinical Trials to share more. In the following video, like their presentation, they showcase the power of this approach by exploring how they interrogate the entire clinical data set independently and objectively using a comprehensive suite of statistical algorithms to determine exactly where data anomalies are present in centers, regions, countries and subjects. Unlike other Risk-Based Monitoring techniques which depend on a subjective decision regarding the data to analyse and the most appropriate threshold of risk, this approach leaves no stone unturned in assessing data quality, allowing sponsors to target resource on all ‘at risk’ centers quickly and easily. The following video describes how to harness these powerful statistical techniques to improve data quality and reduce cost:
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to email@example.com.